Abnormal neurocirculatory control during exercise in humans with chronic renal failure

Autonomic Neuroscience: Basic and Clinical

Volumn 188, Issue , 2015, Pages 74-81

  Park, Jeanie ^a,b   Middlekauff, Holly R ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic renal failure; Exercise; Sympathetic nerve activity

Indexed keywords

NITROPRUSSIDE SODIUM;

ARTICLE; BLOOD PRESSURE REGULATION; BRAIN CIRCULATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; ELEVATED BLOOD PRESSURE; END STAGE RENAL DISEASE; EXERCISE TOLERANCE; HEMODYNAMICS; HUMAN; ISOMETRIC EXERCISE; MECHANORECEPTOR; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SENSITIZATION; ADRENERGIC SYSTEM; EXERCISE; KIDNEY FAILURE, CHRONIC; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

EXERCISE; HEMODYNAMICS; HUMANS; KIDNEY FAILURE, CHRONIC; MECHANORECEPTORS; MUSCLE, SKELETAL; NITROPRUSSIDE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84922908517     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2014.10.013     Document Type: Article

References (71)

1. Abiose A.K., Aronow W.S., Moreno H., Nair C.K., Blaschke T.F., Hoffman B.B. Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin. Am. J. Ther. 2007, 14:427-434.
2. Adams G.R., Vaziri N.D. Skeletal muscle dysfunction in chronic renal failure: effects of exercise. Am. J. Physiol. Ren. Physiol. 2006, 290:F753-761.
3. Bardin T. Musculoskeletal manifestations of chronic renal failure. Curr. Opin. Rheumatol. 2003, 15:48-54.
4. Batman B.A., Hardy J.C., Leuenberger U.A., Smith M.B., Yang Q.X., Sinoway L.I. Sympathetic nerve activity during prolonged rhythmic forearm exercise. J. Appl. Physiol. 1994, 76:1077-1081.
5. Campese V.M., Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995, 25:878-882.
6. Campese V.M., Ye S., Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002, 39:519-524.
7. Campese V.M., Ye S., Zhong H., Yanamadala V., Ye Z., Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H695-703.
8. Campese V.M., Shaohua Y., Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005, 46:533-539.
9. Campistol J.M. Uremic myopathy. Kidney Int. 2002, 62:1901-1913.
10. Clark A.L., Poole-Wilson P.A., Coats A.J. Exercise limitation in chronic heart failure: central role of the periphery. J. Am. Coll. Cardiol. 1996, 28:1092-1102.
11. Clyne N. Physical working capacity in uremic patients. Scand. J. Urol. Nephrol. 1996, 30:247-252.
12. Converse R.L., Jacobsen T.N., Jost C.M., Toto R.D., Grayburn P.A., Obregon T.M., Fouad-Tarazi F., Victor R.G. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J. Clin. Invest. 1992, 90:1657-1665.
13. Converse R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., Victor R.G. Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 1992, 327:1912-1918.
14. Dinenno F.A., Joyner M.J. Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracing human skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2576-2584.
15. Dyke C.K., Proctor D.N., Dietz N.M., Joyner M.J. Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J. Physiol. 1995, 488(Pt 1):259-265.
16. Gilligan D.M., Panza J.A., Kilcoyne C.M., Waclawiw M.A., Casino P.R., Quyyumi A.A. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994, 90:2853-2858.
17. Goto C., Higashi Y., Kimura M., Noma K., Hara K., Nakagawa K., Kawamura M., Chayama K., Yoshizumi M., Nara I. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003, 108:530-535.
18. Goto C., Nishioka K., Umemura T., Jitsuiki D., Sakagutchi A., Kawamura M., Chayama K., Yoshizumi M., Higashi Y. Acute moderate-intensity exercise induces vasodilation through an increase in nitric oxide bioavailability in humans. Am. J. Hypertens. 2007, 20:825-830.
19. Grassi G., Quarti-Trevano F., Seravalle G., Arenare F., Volpe M., Furiani S., Dell'Oro R., Mancia G. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011, 57:846-851.
20. Grassi G., Seravalle G., Ghiadoni L., Tripepi G., Bruno R.M., Mancia G., Zoccali C. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011, 6:2620-2627.
21. Hickner R.C., Fisher J.S., Ehsani A.A., Kohrt W.M. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am. J. Physiol. 1997, 273:H405-410.
22. Hye Khan M.A., Sattar M.A., Abdullah N.A., Johns E.J. Influence of combined hypertension and renal failure on functional alpha(1)-adrenoceptor subtypes in the rat kidney. Br. J. Pharmacol. 2008, 153:1232-1241.
23. Jae S.Y., Fernhall B., Heffernan K.S., Kang M., Lee M.K., Choi Y.H., Hong K.P., Ahn E.S., Park W.H. Exaggerated blood pressure response to exercise is associated with carotid atherosclerosis in apparently healthy men. J. Hypertens. 2006, 24:881-887.
24. Johansen K.L. Physical functioning and exercise capacity in patients on dialysis. Adv. Ren. Replace. Ther. 1999, 6:141-148.
25. Johansen K.L., Painter P. Exercise in individuals with CKD. Am. J. Kidney Dis. 2012, 59:126-134.
26. Johansen K.L., Chertow G.M., Ng A.V., Mulligan K., Carey S., Schoenfeld P.Y., Kent-Braun J.A. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000, 57:2564-2570.
27. Katholi R.E., Whitlow P.L., Hageman G.R., Woods W.T. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J. Hypertens. 1984, 2:349-359.
28. Katz S., Krum H., Khan T., Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J. Am. Coll. Cardiol. 1996, 28:585-590.
29. Kaufman M.P. The exercise pressor reflex in animals. Exp. Physiol. 2012, 97:51-58.
30. Kaufman M.P., Hayes S.G. The exercise pressor reflex. Clin. Auton. Res. 2002, 12:429-439.
31. Khan M.H., Sinoway L.I. Muscle reflex control of sympathetic nerve activity in heart failure: the role of exercise conditioning. Heart Fail. Rev. 2000, 5:87-100.
32. Klein I.H., Ligtenberg G., Neumann J., Oey P.L., Koomans H.A., Blankestijn P.J. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J. Am. Soc. Nephrol. 2003, 14:3239-3244.
33. Klein I.H., Ligtenberg G., Oey P.L., Koomans H.A., Blankestijn P.J. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J. Am. Soc. Nephrol. 2003, 14:425-430.
34. Kopple J.D., Storer T., Casburi R. Impaired exercise capacity and exercise training in maintenance hemodialysis patients. J. Ren. Nutr. 2005, 15:44-48.
35. Ligtenberg G., Blankestijn P.J., Oey P.L., Klein I.H., Dijkhorst-Oei L.T., Boomsma F., Wieneke G.H., van Huffelen A.C., Koomans H.A. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N. Engl. J. Med. 1999, 340:1321-1328.
36. Maiorana A., O'Driscoll G., Taylor R., Green D. Exercise and the nitric oxide vasodilator system. Sports Med. 2003, 33:1013-1035.
37. Mallamaci F., Tripepi G., Maas R., Malatino L., Boger R., Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2004, 15:435-441.
38. Mark A.L., Victor R.G., Nerhed C., Wallin B.G. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ. Res. 1985, 57:461-469.
39. Markel T.A., Daley J.C., Hogeman C.S., Herr M.D., Khan M.H., Gray K.S., Kunselman A.R., Sinoway L.I. Aging and the exercise pressor reflex in humans. Circulation 2003, 107:675-678.
40. Matsushita K., van der Velde M., Astor B.C., Woodward M., Levey A.S., de Jong P.E., Coresh J., Gansevoort R.T. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
41. Middlekauff H.R., Nitzsche E.U., Hoh C.K., Hamilton M.A., Fonarow G.C., Hage A., Moriguchi J.D. Exaggerated renal vasoconstriction during exercise in heart failure patients. Circulation 2000, 101:784-789.
42. Middlekauff H.R., Nitzsche E.U., Hoh C.K., Hamilton M.A., Fonarow G.C., Hage A., Moriguchi J.D. Exaggerated muscle mechanoreflex control of reflex renal vasoconstriction in heart failure. J. Appl. Physiol. 2001, 90:1714-1719.
43. Middlekauff H.R., Chiu J., Hamilton M.A., Fonarow G.C., Maclellan W.R., Hage A., Moriguchi J., Patel J. Muscle mechanoreceptor sensitivity in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1937-1943.
44. Middlekauff H.R., Chiu J., Hamilton M.A., Fonarow G.C., Maclellan W.R., Hage A., Moriguchi J., Patel J. Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1956-1962.
45. Moore G.E., Parsons D.B., Stray-Gundersen J., Painter P.L., Brinker K.R., Mitchell J.H. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am. J. Kidney Dis. 1993, 22:277-287.
46. Negrao C.E., Trombetta I.C., Batalha L.T., Ribeiro M.M., Rondon M.U., Tinucci T., Forjaz C.L., Barretto A.C., Halpern A., Villares S.M. Muscle metaboreflex control is diminished in normotensive obese women. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H469-475.
47. Park J., Campese V.M., Middlekauff H.R. Exercise pressor reflex in humans with end-stage renal disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1188-1194.
48. Park J., Campese V.M., Nobakht N., Middlekauff H.R. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J. Appl. Physiol. 2008, 105:1873-1876.
49. Park J., Quyyumi A.A., Middlekauff H.R. Exercise pressor response and arterial baroreflex unloading during exercise in chronic kidney disease. J. Appl. Physiol. 2012, 114:538-549.
50. Qian Q., Hunter L.W., Du H., Ren Q., Han Y., Sieck G.C. Pkd2+/- vascular smooth muscles develop exaggerated vasocontraction in response to phenylephrine stimulation. J. Am. Soc. Nephrol. 2007, 18:485-493.
51. Ravani P., Tripepi G., Malberti F., Testa S., Mallamaci F., Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J. Am. Soc. Nephrol. 2005, 16:2449-2455.
52. Rondon M.U., Laterza M.C., de Matos L.D., Trombetta I.C., Braga A.M., Roveda F., Alves M.J., Krieger E.M., Negrao C.E. Abnormal muscle metaboreflex control of sympathetic activity in never-treated hypertensive subjects. Am. J. Hypertens. 2006, 19:951-957.
53. Rosenmeier J.B., Dinenno F.A., Fritzlar S.J., Joyner M.J. alpha1- and alpha2-adrenergic vasoconstriction is blunted in contracting human muscle. J. Physiol. 2003, 547:971-976.
54. Saltin B. Exercise hyperaemia: magnitude and aspects on regulation in humans. J. Physiol. 2007, 583:819-823.
55. Scherrer U., Pryor S.L., Bertocci L.A., Victor R.G. Arterial baroreflex buffering of sympathetic activation during exercise-induced elevations in arterial pressure. J. Clin. Invest. 1990, 86:1855-1861.
56. Seals D.R., Victor R.G. Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc. Sport Sci. Rev. 1991, 19:313-349.
57. Sharabi Y., Ben-Cnaan R., Hanin A., Martonovitch G., Grossman E. The significance of hypertensive response to exercise as a predictor of hypertension and cardiovascular disease. J. Hum. Hypertens. 2001, 15:353-356.
58. Sietsema K.E., Hiatt W.R., Esler A., Adler S., Amato A., Brass E.P. Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am. J. Kidney Dis. 2002, 39:76-85.
59. Sinoway L.I., Li J. A perspective on the muscle reflex: implications for congestive heart failure. J. Appl. Physiol. 2005, 99:5-22.
60. Sterns D.A., Ettinger S.M., Gray K.S., Whisler S.K., Mosher T.J., Smith M.B., Sinoway L.I. Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation 1991, 84:2034-2039.
61. Stone A.J., Yamauchi K., Kaufman M.P. Purinergic 2X receptors play a role in evoking the exercise pressor reflex in rats with peripheral artery insufficiency. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H396-404.
62. Trombetta I.C., Batalha L.T., Rondon M.U., Laterza M.C., Kuniyoshi F.H., Gowdak M.M., Barretto A.C., Halpern A., Villares S.M., Negrao C.E. Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H974-982.
63. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339:572-575.
64. Victor R.G., Secher N.H., Lyson T., Mitchell J.H. Central command increases muscle sympathetic nerve activity during intense intermittent isometric exercise in humans. Circ. Res. 1995, 76:127-131.
65. Wallin B.G., Esler M., Dorward P., Eisenhofer G., Ferrier C., Westerman R., Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J. Physiol. 1992, 453:45-58.
66. Wallin B.G., Thompson J.M., Jennings G.L., Esler M.D. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J. Physiol. 1996, 491(Pt 3):881-887.
67. Ye S., Ozgur B., Campese V.M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 1997, 51:722-727.
68. Ye S., Zhong H., Yanamadala V., Campese V.M. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am. J. Hypertens. 2002, 15:717-724.
69. Zoccali C. Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?. Kidney Int. 2006, 70:2053-2055.
70. Zoccali C., Bode-Boger S., Mallamaci F., Benedetto F., Tripepi G., Malatino L., Cataliotti A., Bellanuova I., Fermo I., Frolich J., Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001, 358:2113-2117.
71. Zoccali C., Mallamaci F., Parlongo S., Cutrupi S., Benedetto F.A., Tripepi G., Bonanno G., Rapisarda F., Fatuzzo P., Seminara G., Cataliotti A., Stancanelli B., Malatino L.S. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002, 105:1354-1359.